Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U7947AA | IM / LL |
administration of VAXELIS instead of Quadracel; patient receiving extra doses of Hib and hepatitis B antigens.; This non-serious spontaneous safety report, with reference number 2025SA043502 (Inquiry number 02407940), was received by partner on 10-FEB-2025 and forwarded to UBC on 12-FEB-2025 from other health professional. Due to the nature of the events, the causality between the events 'administration of VAXELIS instead of Quadracel' and 'patient receiving extra doses of Hib and hepatitis B antigens.' and Vaxelis was not applicable. Further information is expected.
Prophylaxis
MMRVAXPRO